Sinico Renato A, Sabadini Ettore, Borlandelli Sabrina, Cosci Pablo, Di Toma Luca, Imbasciati Enrico
Unit of Nephrology and Dialysis, Center of Clinical Immunology and Rheumatology, San Carlo Borromeo Hospital, Via Pio Secondo 3, 20153 Milan, Italy.
J Nephrol. 2003 Mar-Apr;16(2):272-6.
Azathioprine (AZA) is a widely-used drug in the treatment of different diseases such as vasculitis, systemic lupus erythematosus, rheumatoid arthritis, inflammatory bowel diseases and in renal transplantation. Side effects of AZA can be classified as toxic, mainly dose related (myelosuppression and hepatotoxicity) and idiosyncratic, mainly dose independent. While the toxic effects are common and well documented, the hypersensitivity reactions are rare and it is not often easy to distinguish them from systemic sepsis or disease recurrence. We report two cases of AZA hypersensitivity occurring in patients with anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis each mimicking a vasculitis relapse or a septic complication of immunosuppression, as well as a review of the literature.
硫唑嘌呤(AZA)是一种广泛用于治疗多种疾病的药物,如血管炎、系统性红斑狼疮、类风湿性关节炎、炎症性肠病以及肾移植。AZA的副作用可分为毒性副作用,主要与剂量相关(骨髓抑制和肝毒性)以及特异质性副作用,主要与剂量无关。虽然毒性作用常见且有充分记录,但过敏反应罕见,而且往往不容易将它们与全身性脓毒症或疾病复发区分开来。我们报告了两例抗中性粒细胞胞浆抗体(ANCA)相关血管炎患者发生的AZA过敏反应,每例都酷似血管炎复发或免疫抑制的脓毒症并发症,并对相关文献进行了综述。